Oragenics Inc. – Filings and Transcripts

NYSE American: OGEN
Share price (9/18/26): $0.48
Market cap (9/18/26): $2.151 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Shelf registration – amended

Shelf registration

Registration of securities for employees

Prospectus supplement for primary offering

Initial registration of new securities – amended

Ownership Filter

Sabby Management, LLC

News Filter

Chief Medical Officer to Present at IPAC-RS 2026 Nasal Innovation Forum

Reports Continued Clinical Progress, Provides Regulatory and NYSE American Listing Update

Material Definitive Agreement, Change in Directors, Officers or Compensation, Shareholder Vote Results, Financial Statements or Exhibits

Provides Investor Update a Message From Our Chief Executive Officer

Signs Letter of Intent to License CardioDialysis™ Technology From Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC